87 related articles for article (PubMed ID: 10632566)
1. Changes of glycosylation of serum proteins in Sjögren's syndrome: correlation with interleukin-6 and soluble interleukin-2 receptor.
Saso L; Valentini G; Riccieri V; Spadaro A; Zoppini A; Silvestrini B
IUBMB Life; 1999 Oct; 48(4):385-90. PubMed ID: 10632566
[TBL] [Abstract][Full Text] [Related]
2. Serum level of IL-6 in patients with primary and secondary Sjögren's syndrome.
Slezák R; Krejsek J; Kopecký O; Jelenová H
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(2):59-60. PubMed ID: 8584859
[TBL] [Abstract][Full Text] [Related]
3. Elevated tear interleukin-6 levels in patients with Sjögren syndrome.
Tishler M; Yaron I; Geyer O; Shirazi I; Naftaliev E; Yaron M
Ophthalmology; 1998 Dec; 105(12):2327-9. PubMed ID: 9855167
[TBL] [Abstract][Full Text] [Related]
4. Immunohistologic markers of immune activation and changes of glycosylation of serum proteins in primary Sjögren's syndrome.
Riccieri V; Spadaro A; Saso L; Valentini G; Taccari E; Silvestrini B
Clin Exp Rheumatol; 2001; 19(1):53-8. PubMed ID: 11247326
[TBL] [Abstract][Full Text] [Related]
5. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjögren's syndrome in a Hungarian cohort.
Márka M; Bessenyei B; Zeher M; Semsei I
Scand J Immunol; 2005 Nov; 62(5):474-80. PubMed ID: 16305644
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble CD44 in primary Sjögren's syndrome.
Levesque MC; Mackin DA; Fleming JA; St Clair EW
J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
Chodorowska G; Czelej D
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of interleukin 10 in Sjögren's syndrome; correlation with increased IgG1.
Perrier S; Serre AF; Dubost JJ; Beaujon G; Plazonnet MP; Albuisson E; Sauvezie B
J Rheumatol; 2000 Apr; 27(4):935-9. PubMed ID: 10782819
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
Czelej D; Chodorowska G; Lechowska-Mazur I
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
[TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome with myalgia is associated with subnormal secretion of cytokines by peripheral blood mononuclear cells.
Eriksson P; Andersson C; Ekerfelt C; Ernerudh J; Skogh T
J Rheumatol; 2004 Apr; 31(4):729-35. PubMed ID: 15088299
[TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
[TBL] [Abstract][Full Text] [Related]
13. Intense correlation between protein-conjugated acrolein and primary Sjögren's syndrome.
Higashi K; Yoshida M; Igarashi A; Ito K; Wada Y; Murakami S; Kobayashi D; Nakano M; Sohda M; Nakajima T; Narita I; Toida T; Kashiwagi K; Igarashi K
Clin Chim Acta; 2010 Mar; 411(5-6):359-63. PubMed ID: 19968980
[TBL] [Abstract][Full Text] [Related]
14. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
15. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
[TBL] [Abstract][Full Text] [Related]
16. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association.
Friedman J; Schattner A; Shvidel L; Berrebi A
Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153
[TBL] [Abstract][Full Text] [Related]
17. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
Zadura AF; Theander E; Blom AM; Trouw LA
Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
[TBL] [Abstract][Full Text] [Related]
18. Changes of glycosylation of serum proteins in psoriatic arthritis, studied by enzyme-linked lectin assay (ELLA), using concanavalin A.
Saso L; Valentini G; Giardino AM; Spadaro A; Riccieri V; Zoppini A; Silvestrini B
Biochem Mol Biol Int; 1998 Dec; 46(5):867-75. PubMed ID: 9861440
[TBL] [Abstract][Full Text] [Related]
19. The significance of salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with Sjögren's syndrome.
Boras VV; Cikes N; Lukac J; Cekić-Arambasin A; Virag M; Bosnjak A
Coll Antropol; 2004; 28 Suppl 2():305-9. PubMed ID: 15571105
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
Yoon KC; Jeong IY; Park YG; Yang SY
Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
